COMMUNIQUÉS West-GlobeNewswire

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

03/05/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 3 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Medibio Receives CE Certification

03/05/2018 - 04:00

CE certification opens doors for further commercialization SYDNEY, Australia and MINNEAPOLIS, May 02, 2018 (GLOBE NEWSWIRE) -- Medibio Limited ( MEB or the Company ) (ASX:MEB) (OTCQB:MDBIF), a mental health technology [...]

Summary Judgment Granted Upholding the Validity of Formulation Patent Protecting RELISTOR® Injection

03/05/2018 - 02:05

RELISTOR® Injection Protected from Generic Competition Until 2024 NEW YORK, May 02, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ) reported that its partner Valeant Pharmaceuticals [...]

Achaogen Announces FDA Advisory Committee Voted Unanimously in Favor of Plazomicin for Treatment of Adults with Complicated Urinary Tract Infections

02/05/2018 - 23:12

SOUTH SAN FRANCISCO, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram- [...]

Inspire Medical Systems, Inc. Announces Pricing of Initial Public Offering

02/05/2018 - 23:00

MINNEAPOLIS, May 02, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP ) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

FDA updates Trintellix® (vortioxetine) label to include data showing improvement in processing speed, an important aspect of cognitive function in acute Major Depressive Disorder (MDD)

02/05/2018 - 22:40

Trintellix ® (vortioxetine) is the first FDA-approved treatment for MDD to have data in the U.S. Prescribing Information showing a positive effect on processing speed, an aspect of cognitive function that is impaired in [...]

EDAP TMS SA : EDAP TMS SA to Announce First Quarter 2018 Financial Results on Monday, May 14

02/05/2018 - 22:31

LYON, France, May 2, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the first quarter ended March 31, 2018, after the close [...]

Avivagen Announces the Issuance of Shares

02/05/2018 - 22:30

OTTAWA, May 02, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, [...]

Cara Therapeutics to Announce First Quarter 2018 Financial Results on May 9, 2018

02/05/2018 - 22:30

STAMFORD, Conn., May 02, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA ), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]

Zafgen to Present at Deutsche Bank 43rd Annual Health Care Conference

02/05/2018 - 22:30

BOSTON, May 02, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq: ZFGN ), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]

Clearside Biomedical to Report First Quarter 2018 Financial Results on May 9, 2018 – Conference Call to Follow

02/05/2018 - 22:30

ALPHARETTA, Ga., May 02, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, [...]

Dova Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 9, 2018

02/05/2018 - 22:30

DURHAM, N.C., May 02, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) will host a conference call on Wednesday, May 9, 2018 at 4:30 p.m. ET to discuss first quarter 2018 financial results and recent [...]

Globus Medical Reports First Quarter 2018 Results

02/05/2018 - 22:15

AUDUBON, Pa., May 02, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2018. Worldwide [...]

Dynavax to Host First Quarter 2018 Financial Results Conference Call

02/05/2018 - 22:15

BERKELEY, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX ) today announced that it will report financial results for the first quarter ended March 31, 2018 after market close on [...]

The Ensign Group Reports First Quarter Results

02/05/2018 - 22:13

Conference Call and Webcast scheduled for tomorrow, May 3, 2018 at 10:00 am PT MISSION VIEJO, Calif., May 02, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign™ group of [...]

Humanigen Announces Preclinical Findings Presented on Lenzilumab’s Potential to Optimize CAR-T Therapy

02/05/2018 - 22:10

Lenzilumab effectively neutralizes GM-CSF CAR-T cells maintained robust anti-tumor activity in combination with lenzilumab GM-CSF depletion by lenzilumab may increase CAR-T expansion BRISBANE, Calif., May 02, 2018 ( [...]

Sandoz receives complete response letter from the US FDA for proposed biosimilar rituximab

02/05/2018 - 22:06

Holzkirchen, May 2, 2018 - Sandoz, a Novartis division, announced today that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the Biologics Licensing Application (BLA) for [...]

TRACON to Report First Quarter 2018 Company Highlights and Financial Results on May 9, 2018

02/05/2018 - 22:05

SAN DIEGO, May 02, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON ), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]

miRagen Therapeutics Presents New Preclinical Data Supporting use of MicroRNA-Targeted Therapies for Ophthalmic Diseases

02/05/2018 - 22:05

Dosing with microRNA mimics of the microRNA-183/96/182 cluster led to functional improvement of photoreceptors and vision in retinal degeneration model MRG-201 dosing inhibited the expression of multiple factors [...]